Phase 1 clinical trial of marizomib (MRZ, NPI-0052) in patients with advanced malignancies including multiple myeloma: study NPI-0052-102 (NCT00629473) final results
Clinical Lymphoma, Myeloma & Leukemia(2015)
摘要
PO-332 Phase 1 clinical trial of marizomib (MRZ, NPI-0052) in patients with advanced malignancies including multiple myeloma: study NPI-0052-102 (NCT00629473) final results S.J. Harrison, L. Catley, T. Price, M.J. Millward, P. Padrik, C.R. Underhill, P.K. Cannell, F.J. Burrows, S.D. Reich, M. Trikha, A. Spencer The Peter MacCallum Cancer Centre; Mater Adult Hospital; Queen Elizabeth Hospital; Sir Charles; Tartu University Hospital; Border Medical Oncology and University of New South Wales; Royal Perth Hospital; Triphase Accelerator; Alfred Health-Monash University
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要